By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French molecular diagnostics company IntegraGen has been awarded a €1.6 million ($2.4 million) interest-free loan from the French government to develop cancer biomarker tools, the company said Wednesday.

IntegraGen will use the loan from OSEO (the French state innovation agency) to partner with the French National Institute of Health and Medical Research (INSERM) to develop biomarker panels for personalized medicine and management of liver and colon cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.